United States · FDA National Drug Code directory
STEGLATRO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-5364_17e6fd06-3cc6-4bad-8809-76e38dbc4471
- Product NDC
- 0006-5364
- Form
- TABLET, FILM COATED
- Composition / generic term
- ertugliflozin
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20171219
- Source listing expiry
- 20271231
Source-listed ingredients
- ERTUGLIFLOZIN PIDOLATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (0006-5364-03) · 0006-5364-03
- 90 TABLET, FILM COATED in 1 BOTTLE (0006-5364-06) · 0006-5364-06
- 500 TABLET, FILM COATED in 1 BOTTLE (0006-5364-07) · 0006-5364-07
- 2 BOTTLE in 1 CARTON (0006-5364-09) / 7 TABLET, FILM COATED in 1 BOTTLE (0006-5364-08) · 0006-5364-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →